Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Influenza, Human × Nivolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 33 Carcinoma, Non-Small-Cell Lung 29 Carcinoma, Renal Cell 21 Neoplasm Metastasis 16 Lung Neoplasms 16 Carcinoma, Hepatocellular 14 Colorectal Neoplasms 10 Pancreatic Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Carcinoma, Transitional Cell 8 Urinary Bladder Neoplasms 7 Neoplasms 7 Multiple Myeloma 7 Breast Neoplasms 7 Small Cell Lung Carcinoma 6 Hodgkin Disease 6 Head and Neck Neoplasms 6 Triple Negative Breast Neoplasms 5 Ovarian Neoplasms 5 Skin Neoplasms 4 Myelodysplastic Syndromes 4 Lymphoma 4 Kidney Neoplasms 4 Hematologic Neoplasms 4 Glioblastoma 4 Advanced Cancer 4 Prostatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Liver Neoplasms 3 Fallopian Tube Neoplasms 3

Interventions

Influenza Vaccines 2 Nivolumab 1 Ipilimumab 1 Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Diphtheria-Tetanus Vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05116917 2024-05-28

INFLUENCE

Herlev Hospital

Phase 2 Terminated

Gastrointestinal

Influenza, Human, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡